3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Neoplasms
1
Multi Drug Resistant Organisms
1
Meningioma
1
Leukemia, Hairy Cell
1
Hodgkin Disease
1
Diabetes Mellitus
1
Brain Neoplasms
1
Interventions
Peripheral Blood Stem Cell Transplantation
24
Mycophenolic Acid
16
Cyclophosphamide
15
fludarabine phosphate
14
Tacrolimus
13
Rituximab
13
Cyclosporine
13
Whole-Body Irradiation
12
Filgrastim
10
Therapeutics
9
Radiotherapy
8
Psychiatric Rehabilitation
8
Flow Cytometry
8
Etoposide
8
Methylprednisolone
7
Methotrexate
7
Busulfan
7
Antilymphocyte Serum
7
Polymerase Chain Reaction
6
obinutuzumab
4
Vemurafenib
4
Ondansetron
4
Melphalan
4
Granulocyte Colony-Stimulating Factor
4
Cord Blood Stem Cell Transplantation
4
Cladribine
4
Bortezomib
4
Transplantation
3
Sirolimus
3
Lenalidomide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Leukemia, Hairy Cell
×
Verapamil
×
Clear all
NCT04233034
2024-11-27
CLVer
Jaeb Center for Health Research
Phase 3
Completed
113 enrolled
42 charts